Dashboard
Manage Tickers

SIBNSI-BONE, Inc.

Nasdaq si-bone.com


$ 15.32 $ -0.21 (-1.35 %)    

Friday, 10-May-2024 15:59:50 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 15.33
$ 15.61
$ 0.00 x 0
$ 0.00 x 0
$ 15.18 - $ 15.74
$ 13.96 - $ 29.51
449,563
na
627.52M
$ 1.45
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 02-27-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-02-2023 03-31-2023 10-Q
6 03-02-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-01-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-04-2021 06-30-2021 10-Q
13 05-04-2021 03-31-2021 10-Q
14 03-10-2021 12-31-2020 10-K
15 11-03-2020 09-30-2020 10-Q
16 08-04-2020 06-30-2020 10-Q
17 05-05-2020 03-31-2020 10-Q
18 03-11-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-07-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 03-14-2019 12-31-2018 10-K
23 11-29-2018 09-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

morgan-stanley-maintains-overweight-on-si-bone-lowers-price-target-to-25
Morgan Stanley Maintains Overweight on SI-...
05/07/2024 16:41:00

Morgan Stanley analyst Drew Ranieri maintains SI-BONE (NASDAQ:SIBN) with a Overweight and lowers the price target from $26 t...

jmp-securities-reiterates-market-outperform-on-si-bone-maintains-32-price-target
JMP Securities Reiterates Market Outperfor...
05/07/2024 16:14:11

JMP Securities analyst David Turkaly reiterates SI-BONE (NASDAQ:SIBN) with a Market Outperform and maintains $32 price target.

si-bone-launches-ifuse-bedrock-granite-implant-system-and-completes-inaugural-surgical-procedures
SI-BONE Launches iFuse Bedrock Granite Imp...
05/07/2024 13:04:14

a-closer-look-at-6-analyst-recommendations-for-si-bone
A Closer Look at 6 Analyst Recommendations...
05/07/2024 13:00:50

needham-reiterates-buy-on-si-bone-maintains-27-price-target
Needham Reiterates Buy on SI-BONE, Maintai...
05/07/2024 09:51:34

Needham analyst David Saxon reiterates SI-BONE (NASDAQ:SIBN) with a Buy and maintains $27 price target.

si-bone-updates-fy24-worldwide-revenue-guidance-from-162m-165m-to-164m-166m-vs-163631m-est
SI-BONE Updates FY24 Worldwide Revenue Gui...
05/06/2024 21:03:08

si-bone-q1-2024-gaap-eps-027-beats-032-estimate-sales-37867m-beat-36494m-estimate
SI-BONE Q1 2024 GAAP EPS $(0.27) Beats $(0...
05/06/2024 20:48:26

SI-BONE (NASDAQ:SIBN) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.32) by 15...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
05/06/2024 20:31:06

needham-reiterates-buy-on-si-bone-maintains-27-price-target
Needham Reiterates Buy on SI-BONE, Maintai...
04/03/2024 15:34:24

Needham analyst David Saxon reiterates SI-BONE (NASDAQ:SIBN) with a Buy and maintains $27 price target.

peeling-back-the-layers-exploring-si-bone-through-analyst-insights
Peeling Back The Layers: Exploring SI-BONE...
03/28/2024 19:00:31

piper-sandler-initiates-coverage-on-si-bone-with-overweight-rating-announces-price-target-of-25
Piper Sandler Initiates Coverage On SI-BON...
03/28/2024 16:19:23

Piper Sandler analyst Matt O'Brien initiates coverage on SI-BONE (NASDAQ:SIBN) with a Overweight rating and announces Pr...

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
02/27/2024 17:31:10

morgan-stanley-maintains-overweight-on-si-bone-raises-price-target-to-26
Morgan Stanley Maintains Overweight on SI-...
02/27/2024 16:05:26

Morgan Stanley analyst Drew Ranieri maintains SI-BONE (NASDAQ:SIBN) with a Overweight and raises the price target from $25 t...

beyond-the-numbers-4-analysts-discuss-si-bone-stock
Beyond The Numbers: 4 Analysts Discuss SI-...
02/27/2024 15:00:31

cantor-fitzgerald-maintains-overweight-on-si-bone-maintains-25-price-target
Cantor Fitzgerald Maintains Overweight on ...
02/27/2024 14:12:41

Cantor Fitzgerald analyst Ross Osborn maintains SI-BONE (NASDAQ:SIBN) with a Overweight and maintains $25 price target.

truist-securities-reiterates-buy-on-si-bone-lowers-price-target-to-24
Truist Securities Reiterates Buy on SI-BON...
02/27/2024 14:02:31

Truist Securities analyst Samuel Brodovsky reiterates SI-BONE (NASDAQ:SIBN) with a Buy and lowers the price target from $26 ...

si-bone-sees-fy24-revenue-162m-165m-vs-159058m-est
SI-BONE Sees FY24 Revenue $162M-$165M Vs $...
02/26/2024 21:38:23

recap-si-bone-q4-earnings
Recap: SI-BONE Q4 Earnings
02/26/2024 21:25:07

si-bone-q4-2023-gaap-eps-027-misses-026-estimate-sales-3886m-beat-3761m-estimate
SI-BONE Q4 2023 GAAP EPS $(0.27) Misses $(...
02/26/2024 21:24:47

SI-BONE (NASDAQ:SIBN) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.26) by ...

earnings-scheduled-for-february-26-2024
Earnings Scheduled For February 26, 2024
02/26/2024 09:47:53

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION